# Sangamo Therapeutics, Inc: Form 8-K, filed Apr 29, 2026

- Company: [Sangamo Therapeutics, Inc](/companies/sgmoq.md) (CIK 1001233)
- Form: 8-K
- Filed: 2026-04-29
- Accepted by EDGAR: Apr 29, 2026, 08:37 ET
- Period: 2026-04-28
- Accession: 0001628280-26-028128
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1001233/000162828026028128/sgmo-20260428.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1001233/000162828026028128/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1001233/000162828026028128/sgmo-20260428.htm

Filed Apr 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-028128. Last ingested by Listed: Oct 27, 2026, 16:02 ET. No prices; not investment advice.